内镜超声在肝癌诊治中的应用进展

刘攀; 于守君; 成雨

doi:10.3969/j.issn.1001-5256.2021.08.041

内镜超声在肝癌诊治中的应用进展

DOI: 10.3969/j.issn.1001-5256.2021.08.041

刘攀^a,
于守君^a, ,,
成雨^b

a.
滨州医学院烟台附属医院肝胆胰脾外科微创诊疗中心，山东烟台 264100
b.
滨州医学院烟台附属医院肝胆胰脾外科，山东烟台 264100

利益冲突声明：所有作者均声明不存在利益冲突。

作者贡献声明：刘攀负责资料收集与分析，撰写论文；成雨参与资料分析，修改论文；于守君负责拟定写作思路，指导撰写文章并最后定稿。

详细信息

通信作者:
于守君，1224267547@qq.com

中图分类号: R735.7
计量
- 文章访问数: 588
- HTML全文浏览量: 312
- PDF下载量: 45
- 被引次数: 0
出版历程
- 收稿日期: 2021-01-02
- 录用日期: 2021-02-01
- 出版日期: 2021-08-20

Advances in the application of endoscopic ultrasound in the diagnosis and treatment of liver cancer

Pan LIU^a,
Shoujun YU^{a
, ,},
Yu CHENG^b

a.
Center of Minimally Invasive Diagnosis and Treatment of Hepatobiliary, Pancreatic and Splenic Surgery, The Affiliated Yantai Hospital of Binzhou Medical University, Yantai, Shandong 264100, China
b.
Department of Hepatobiliary, Pancreatic and Splenic Surgery, The Affiliated Yantai Hospital of Binzhou Medical University, Yantai, Shandong 264100, China

摘要

摘要: 肝癌是我国最常见的恶性肿瘤之一，其发病率呈逐年上升趋势。因此，肝癌的早期诊断和治疗显得尤为重要，在诸多检查中，内镜超声(EUS)可以对肝脏和胆道系统进行近距离的扫描，对肝癌的诊断、治疗和分期起着不可或缺的作用。现概述EUS在肝癌诊断和治疗中的应用现状及前景，以期为临床肝癌的诊治提供参考。
- 肝肿瘤 /
- 腔内超声检查 /
- 诊断 /
- 治疗学
Abstract: Liver cancer is one of the most common malignant tumors in China, and its incidence rate is increasing year by year. Therefore, the early diagnosis and treatment of liver cancer is of great importance. Among various examinations, endoscopic ultrasound (EUS) can perform close scanning of the liver and the biliary system, which plays an indispensable role in the diagnosis, treatment, and staging of liver cancer. This article reviews the current status and future perspectives of EUS in the diagnosis and treatment of liver cancer, in order to provide a reference for the clinical diagnosis and treatment of liver cancer.
- Liver Neoplasms /
- Endosonography /
- Diagnosis /
- Therapeutics

HTML全文

参考文献(46)

[1]	WU M, LIU Z, LI X, et al. Dynamic changes in serum markers and their utility in the early diagnosis of all stages of hepatitis B-associated hepatocellular carcinoma[J]. Onco Targets Ther, 2020, 13: 827-840. DOI: 10.2147/OTT.S229835.
[2]	HENNEDIGE T, VENKATESH SK. Imaging of hepatocellular carcinoma: Diagnosis, staging and treatment monitoring[J]. Cancer Imaging, 2013, 12: 530-547. DOI: 10.1102/1470-7330.2012.0044.
[3]	SINGH P, MUKHOPADHYAY P, BHATT B, et al. Endoscopic ultrasound versus CT scan for detection of the metastases to the liver: Results of a prospective comparative study[J]. J Clin Gastroenterol, 2009, 43(4): 367-373. DOI: 10.1097/MCG.0b013e318167b8cc.
[4]	ICHIM VA, CHIRA RI, MIRCEA PA, et al. Accuracy of endoscopic ultrasound-guided biopsy of focal liver lesions[J]. Med Ultrason, 2020, 22(1): 20-25. DOI: 10.11152/mu-2078.
[5]	SINGH P, ERICKSON RA, MUKHOPADHYAY P, et al. EUS for detection of the hepatocellular carcinoma: Results of a prospective study[J]. Gastrointest Endosc, 2007, 66(2): 265-273. DOI: 10.1016/j.gie.2006.10.053.
[6]	LANGE A, MUNIRAJ T, ASLANIAN HR. Endoscopic ultrasound for the diagnosis and staging of liver tumors[J]. Gastrointest Endosc Clin N Am, 2019, 29(2): 339-350. DOI: 10.1016/j.giec.2018.12.005.
[7]	BEYER LP, WASSERMANN F, PREGLER B, et al. Characterization of focal liver lesions using CEUS and MRI with liver-specific contrast media: Experience of a single radiologic center[J]. Ultraschall Med, 2017, 38(6): 619-625. DOI: 10.1055/s-0043-105264.
[8]	OH D, SEO DW, HONG SM, et al. The usefulness of contrast-enhanced harmonic EUS-guided fine-needle aspiration for evaluation of hepatic lesions (with video)[J]. Gastrointest Endosc, 2018, 88(3): 495-501. DOI: 10.1016/j.gie.2018.05.019.
[9]	MINAGA K, KITANO M, NAKAI A, et al. Improved detection of liver metastasis using Kupffer-phase imaging in contrast-enhanced harmonic EUS in patients with pancreatic cancer (with video)[J]. Gastrointest Endosc, 2021, 93(2): 433-441. DOI: 10.1016/j.gie.2020.06.051.
[10]	JOHNSON KD, LAOVEERAVAT P, YEE EU, et al. Endoscopic ultrasound guided liver biopsy: Recent evidence[J]. World J Gastrointest Endosc, 2020, 12(3): 83-97. DOI: 10.4253/wjge.v12.i3.83.
[11]	SHUJA A, ALKHASAWNEH A, FIALHO A, et al. Comparison of EUS-guided versus percutaneous and transjugular approaches for the performance of liver biopsies[J]. Dig Liver Dis, 2019, 51(6): 826-830. DOI: 10.1016/j.dld.2019.01.006.
[12]	ALI AH, PANCHAL S, RAO DS, et al. The efficacy and safety of endoscopic ultrasound-guided liver biopsy versus percutaneous liver biopsy in patients with chronic liver disease: A retrospective single-center study[J]. J Ultrasound, 2020, 23(2): 157-167. DOI: 10.1007/s40477-020-00436-z.
[13]	BHATIA V, VARADARAJULU S. Endoscopic ultrasonography-guided tissue acquisition: How to achieve excellence[J]. Dig Endosc, 2017, 29(4): 417-430. DOI: 10.1111/den.12823.
[14]	NGUYEN P, FENG JC, CHANG KJ. Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) of liver lesions[J]. Gastrointest Endosc, 1999, 50(3): 357-361. DOI: 10.1053/ge.1999.v50.97208.
[15]	OH D, SEO DW, HONG SM, et al. Endoscopic ultrasound-guided fine-needle aspiration can target right liver mass[J]. Endosc Ultrasound, 2017, 6(2): 109-115. DOI: 10.4103/2303-9027.204813.
[16]	CHON HK, YANG HC, CHOI KH, et al. Endoscopic ultrasound-guided liver biopsy using a core needle for hepatic solid mass[J]. Clin Endosc, 2019, 52(4): 340-346. DOI: 10.5946/ce.2018.175.
[17]	CHEN F, BAO H, DENG Z, et al. Endoscopic ultrasound-guided sampling using core biopsy needle for diagnosis of left-lobe hepatocellular carcinoma in patients with underlying cirrhosis[J]. J Cancer Res Ther, 2020, 16(5): 1100-1105. DOI: 10.4103/jcrt.JCRT_723_19.
[18]	SCHULMAN AR, THOMPSON CC, ODZE R, et al. Optimizing EUS-guided liver biopsy sampling: Comprehensive assessment of needle types and tissue acquisition techniques[J]. Gastrointest Endosc, 2017, 85(2): 419-426. DOI: 10.1016/j.gie.2016.07.065.
[19]	CHING-COMPANIONI RA, DIEHL DL, JOHAL AS, et al. 19 G aspiration needle versus 19 G core biopsy needle for endoscopic ultrasound-guided liver biopsy: A prospective randomized trial[J]. Endoscopy, 2019, 51(11): 1059-1065. DOI: 10.1055/a-0956-6922.
[20]	MOHAN BP, SHAKHATREH M, GARG R, et al. Efficacy and safety of EUS-guided liver biopsy: A systematic review and meta-analysis[J]. Gastrointest Endosc, 2019, 89(2): 238-246. DOI: 10.1016/j.gie.2018.10.018.
[21]	RUSTEMOVIC N, HRSTIC I, OPACIC M, et al. EUS elastography in the diagnosis of focal liver lesions[J]. Gastrointest Endosc, 2007, 66(4): 823-824; discussion 824. DOI: 10.1016/j.gie.2007.06.047.
[22]	European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH clinical practice guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis[J]. J Hepatol, 2015, 63(1): 237-264. DOI: 10.1016/j.jhep.2015.04.006.
[23]	SANDULESCU L, PADUREANU V, DUMITRESCU C, et al. A pilot study of real time elastography in the differentiation of focal liver lesions[J]. Curr Health Sci J, 2012, 38(1): 32-35.
[24]	MA X, ZHAN W, ZHANG B, et al. Elastography for the differentiation of benign and malignant liver lesions: A meta-analysis[J]. Tumour Biol, 2014, 35(5): 4489-4497. DOI: 10.1007/s13277-013-1591-4.
[25]	JIAO Y, DONG F, WANG H, et al. Shear wave elastography imaging for detecting malignant lesions of the liver: A systematic review and pooled meta-analysis[J]. Med Ultrason, 2017, 19(1): 16-22. DOI: 10.11152/mu-925.
[26]	HU X, HUANG X, CHEN H, et al. Diagnostic effect of shear wave elastography imaging for differentiation of malignant liver lesions: A meta-analysis[J]. BMC Gastroenterol, 2019, 19(1): 60. DOI: 10.1186/s12876-019-0976-2.
[27]	SCOPELLITI F, PEA A, CONIGLIARO R, et al. Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer[J]. Surg Endosc, 2018, 32(9): 4022-4028. DOI: 10.1007/s00464-018-6217-x.
[28]	DHALIWAL A, KOLLI S, DHINDSA BS, et al. Efficacy of EUS-RFA in pancreatic tumors: Is it ready for prime time? A systematic review and meta-analysis[J]. Endosc Int Open, 2020, 8(10): e1243-e1251. DOI: 10.1055/a-1221-5012.
[29]	de NUCCI G, DELLA CORTE C, REATI R, et al. Endoscopic ultrasound-guided radiofrequency ablation for hepatocellular carcinoma in cirrhosis: A case report test for efficacy and future perspectives[J]. Endosc Int Open, 2020, 8(11): e1713-e1716. DOI: 10.1055/a-1236-3105.
[30]	LUCCHINA N, TSETIS D, IERARDI AM, et al. Current role of microwave ablation in the treatment of small hepatocellular carcinomas[J]. Ann Gastroenterol, 2016, 29(4): 460-465. DOI: 10.20524/aog.2016.0066.
[31]	CHUA T, FAIGEL DO. Endoscopic ultrasound-guided ablation of liver tumors[J]. Gastrointest Endosc Clin N Am, 2019, 29(2): 369-379. DOI: 10.1016/j.giec.2018.11.007.
[32]	LU J, ZHU HD, TENG GJ, et al. Role of interventional therapy in the downstaging of advanced liver cancer[J]. J Clin Hepatol, 2020, 36(2): 272-276. DOI: 10.3969/j.issn.1001-5256.2020.02.006. 陆建, 朱海东, 滕皋军, 等. 介入治疗在中晚期肝癌降期中的作用[J]. 临床肝胆病杂志, 2020, 36(2): 272-276. DOI: 10.3969/j.issn.1001-5256.2020.02.006.
[33]	WEIS S, FRANKE A, BERG T, et al. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma[J]. Cochrane Database Syst Rev, 2015, 1: CD006745. DOI: 10.1002/14651858.CD006745.pub3.
[34]	CHOI JH, PARK DH, KIM MH, et al. Outcomes after endoscopic ultrasound-guided ethanol-lipiodol ablation of small pancreatic neuroendocrine tumors[J]. Dig Endosc, 2018, 30(5): 652-658. DOI: 10.1111/den.13058.
[35]	TEOH AY, CHONG CC, CHAN AW, et al. EUS-guided alcohol injection of pancreatic neuroendocrine tumor[J]. Gastrointest Endosc, 2015, 82(1): 167. DOI: 10.1016/j.gie.2015.01.047.
[36]	XU ZF, XIE XY, CUI Y, et al. Initial clinical experience of ethanol ablation with endoscopic ultrasonography guidance for 10 cases of hepatocellular carcinoma which are difficult to reach by percutaneous mode[J/CD]. Chin J Med Ultrasound (Electronic edition), 2011, 8(9): 1964-1969. DOI: 10.3877/cma.j.issn.1672-6448.2011.09.015. 徐作峰, 谢晓燕, 崔毅, 等. 超声内镜引导无水酒精治疗特殊部位肝癌10例[J/CD]. 中华医学超声杂志(电子版), 2011, 8(9): 1964-1969. DOI: 10.3877/cma.j.issn.1672-6448.2011.09.015.
[37]	NAKAJI S, HIRATA N, KOBAYASHI M, et al. Endoscopic ultrasonography-guided ethanol injection as a treatment for ruptured hepatocellular carcinoma in the left hepatic lobe[J]. Endoscopy, 2015, 47 Suppl 1: e558-e560. DOI: 10.1055/s-0034-1393394.
[38]	NAKAJI S, HIRATA N, MIKATA R, et al. Clinical outcomes of endoscopic ultrasound-guided ethanol injection for hepatocellular carcinoma in the caudate lobe[J]. Endosc Int Open, 2016, 4(10): e1111-e1115. DOI: 10.1055/s-0042-116146.
[39]	SEO DW. EUS-guided antitumor therapy for pancreatic tumors[J]. Gut Liver, 2010, 4 Suppl 1: s76-s81. DOI: 10.5009/gnl.2010.4.S1.S76.
[40]	LEVY MJ, ALBERTS SR, BAMLET WR, et al. EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer[J]. Gastrointest Endosc, 2017, 86(1): 161-169. DOI: 10.1016/j.gie.2016.11.014.
[41]	POGGI G, TOSORATTI N, MONTAGNA B, et al. Microwave ablation of hepatocellular carcinoma[J]. World J Hepatol, 2015, 7(25): 2578-2589. DOI: 10.4254/wjh.v7.i25.2578.
[42]	DING J, JING X, LIU J, et al. Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma[J]. Eur J Radiol, 2013, 82(9): 1379-1384. DOI: 10.1016/j.ejrad.2013.04.025.
[43]	SHI J, SUN Q, WANG Y, et al. Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria[J]. J Gastroenterol Hepatol, 2014, 29(7): 1500-1507. DOI: 10.1111/jgh.12572.
[44]	SONG SY, ZHANG S, LIU F, et al. An experimental study on endoscopic ultrasound-guided microwave ablation for porcine liver and pancreas[J]. Chin J Dig Endosc, 2019, 36(2): 119-123. DOI: 10.3760/cma.j.issn.1007-5232.2019.02.008. 宋世义, 张松, 刘飞, 等. 内镜超声引导下微波消融猪肝脏及胰腺的实验研究[J]. 中华消化内镜杂志, 2019, 36(2): 119-123. DOI: 10.3760/cma.j.issn.1007-5232.2019.02.008.
[45]	JI J, SHI J, BUDHU A, et al. MicroRNA expression, survival, and response to interferon in liver cancer[J]. N Engl J Med, 2009, 361(15): 1437-1447. DOI: 10.1056/NEJMoa0901282.
[46]	CAMPOS S, POLEY JW, van DRIEL L, et al. The role of EUS in diagnosis and treatment of liver disorders[J]. Endosc Int Open, 2019, 7(10): e1262-e1275. DOI: 10.1055/a-0958-2183.